The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication
Open Access
- 3 September 2019
- journal article
- research article
- Published by Wiley in Molecular Genetics & Genomic Medicine
- Vol. 7 (11), e940
- https://doi.org/10.1002/mgg3.940
Abstract
Background Individuals with hypertrophic cardiomyopathy (HCM), even when asymptomatic, are at‐risk for sudden cardiac death and stroke from arrhythmias, making it imperative to identify individuals affected by this familial disorder. Consensus guidelines recommend that first‐degree relatives (FDRs) of a person with HCM undergo serial cardiovascular evaluations. Methods We determined the uptake of family screening in patients with HCM and developed an online video intervention to facilitate family communication and screening. Family screening and genetic testing data were collected through a prospective quality improvement initiative, a standardized clinical assessment and management plan (SCAMP), utilized in an established cardiovascular genetics clinic. Patients were prescribed an online video if screening of their FDRs was incomplete and a pilot study on video utilization and family communication was conducted. Results Two‐hundred and sixteen probands with HCM were enrolled in SCAMP Phase I and 190 were enrolled in SCAMP Phase II. In both phases, probands reported that 51% of FDRs had been screened (382/749 in Phase I, 258/504 in Phase II). Twenty patients participated in a pilot study on video utilization and family communication. Nine participants reported watching the video and six participants reported sharing the video with relatives; however only one participant reported sharing the video with relatives who were not yet aware of the diagnosis of HCM in the family. Conclusion Despite care in a specialized cardiovascular genetics clinic, approximately one half of FDRs of patients with HCM remained unscreened. Online interventions and videos may serve as supplemental tools for patients communicating genetic risk information to relatives.Keywords
Funding Information
- Howard Hughes Medical Institute
- Merck
- Sanofi
- Novartis
- AstraZeneca
- National Institutes of Health (HG007690)
This publication has 29 references indexed in Scilit:
- Genetic Pathogenesis of Hypertrophic and Dilated CardiomyopathyHeart Failure Clinics, 2018
- The impact of an interventional counselling procedure in families with a BRCA1/2 gene mutation: efficacy and safetyFamilial Cancer, 2016
- Factors influencing uptake of familial long QT syndrome genetic testingAmerican Journal of Medical Genetics Part A, 2015
- Disclosing Genetic Information to Family Members About Inherited Cardiac Arrhythmias: An Obligation or a Choice?Journal of Genetic Counseling, 2014
- Family Communication in a Population at Risk for Hypertrophic CardiomyopathyJournal of Genetic Counseling, 2014
- Reduced Uptake of Family Screening in Genotype‐Negative Versus Genotype‐Positive Long QT SyndromeJournal of Genetic Counseling, 2014
- Uptake of Genetic Testing by Relatives of Lynch Syndrome Probands: A Systematic ReviewClinical Gastroenterology and Hepatology, 2013
- Standardized Clinical Assessment And Management Plans (SCAMPs) Provide A Better Alternative To Clinical Practice GuidelinesHealth Affairs, 2013
- Characteristics of Health Information Gatherers, Disseminators, and Blockers Within Families at Risk of Hereditary Cancer: Implications for Family Health Communication InterventionsAmerican Journal of Public Health, 2009
- Cascade testing in familial hypercholesterolaemia: how should family members be contacted?European Journal of Human Genetics, 2005